
-
Tajik women speak out against government fashion advice
-
'Hamilton' axes run at prominent US cultural center after Trump takeover
-
Egypt's gem of a museum gears up for grand opening
-
New Zealand to sack senior diplomat after Trump jibe
-
Slipper milestone as Brumbies ready for 'big one' against Blues
-
Hop to Dubai and back 'not ideal' says Miller after South Africa exit
-
Cyclone's fringe lashes eastern Australia
-
France focus on Galthie's midfield ahead of Ireland Six Nations showdown
-
Gibson-Park the man who makes Six Nations title-chasers Ireland tick
-
Juventus lurch between crisis club and Serie A challengers ahead of Atalanta visit
-
US firm targets Moon landing with drill, rovers, hopping drone
-
In El Salvador, a river without fish feeds fear of mining
-
Trump to welcome crypto elite at White House
-
Top seed Zverev ready to win again in Indian Wells
-
Slot hails 'lucky' Liverpool after Elliott goal sinks PSG
-
Christie's first AI art auction sees hits... and plenty of misses
-
Goals 'probably' most important in Bayern career, says Kane
-
Liverpool smash and grab stuns PSG in Champions League as Bayern cruise
-
PGA-LIV deal 'doesn't feel' closer: McIlroy
-
Leverkusen need 'big miracle' to reach Champions League last eight, admits Alonso
-
Trump warns Gaza 'you are dead' if hostages not freed
-
Iranian singer ready 'to pay price for freedom' after 74 lashes
-
Ex-Wimbledon champion Kvitova falls in Indian Wells first round
-
Global stocks rally on German defense push, US pause on auto tariffs
-
Super-sub Elliott hands Liverpool win over PSG in Champions League
-
Raphinha earns 10-man Barca tight first leg win at Benfica
-
Kane brace puts Bayern on course for last eight against Leverkusen
-
Passion driving LeBron to new records after scoring milestone
-
Lyon coach Fonseca banned until November after referee clash
-
Accused IS militant appears in US court over Kabul airport attack
-
Rangers interim boss Barry Ferguson relishing Mourinho clash
-
Trump pauses tariffs for autos as Trudeau call yields no breakthrough
-
Palmer set to answer Chelsea's Conference call
-
Williamson wants New Zealand to learn from India defeat in final
-
New faces at Tom Ford, Dries Van Noten make debuts in Paris
-
Trump tariffs reverberate through Mexico's industrial belt
-
Postecoglou says Europa League a 'great opportunity' for Spurs
-
Deluge of Trump tariffs seen hitting household budgets
-
FIFA to pay $1 billion prize money for Club World Cup
-
US confirms direct talks with Hamas as Israel warns not done in Gaza
-
Coach Walter bemoans execution in South Africa Champions Trophy semi-final loss
-
England boss Borthwick adamant dropped Marcus Smith still a 'game-changer'
-
Inter's strike force seize control of Champions League last-16 tie
-
Trump suspends tariffs for autos as Trudeau call yields no breakthrough
-
Europa League win can change dire Man United season: Amorim
-
'Stable' pope marks start of Lent in hospital
-
Supreme Court rejects Trump bid to freeze $2 bn in foreign aid
-
Chinese hackers indicted in US for Treasury breach, other attacks
-
Ukraine plans new talks with US after intelligence sharing ends
-
Accused IS militant to appear in US court over Kabul airport attack

France warns against weight loss supplements using Garcinia plant
France warned Wednesday against dietary supplements promising weight loss that use the tropical plant Garcinia cambogia after a range of rare but serious side effects including one death were reported.
Garcinia cambogia -- which is also called Garcinia gummi-gutta or Malabar tamarind -- grows in India and Southeast Asia and has a fruit that looks like a pumpkin.
A range of supplements are sold around the world using extracts from the plant advertising its ability to suppress appetite and drive weight loss -- claims not backed by comprehensive scientific evidence.
After investigating the death of a person who took a Garcinia-based supplement -- and looking at other side effects reported in the United States and elsewhere -- French food safety agency ANSES said it "strongly advises" people against consuming the plant.
The plant has been banned from being used medicine since 2012 in France, but continues to be advertised in more 340 dietary supplements, which are mostly available online, the agency said in a statement.
There were 38 cases of serious side effects affecting the liver, pancreas, heart, muscles and mental health reported in France between 2009 and March last year, ANSES said.
These side effects can affect people with a history of psychiatric disorders, pancreatitis or hepatitis -- or who suffer from diabetes, obesity or high blood pressure, the agency added.
People taking antidepressants, antiretrovirals or drugs that affect the liver can also experience side effects.
A 71-year-old woman in France taking blood pressure drugs died of acute hepatitis in 2019 after taking Garcinia-based supplement Slim Metabol. ANSES says her death was "very likely" linked to the supplement, which remains on sale.
However people without a history of health problems can also be affected.
"A 32-year-old woman with no medical history developed myocarditis that led to her requiring a heart transplant," Aymeric Dopter, head of the ANSES nutrition risk assessment unit, told AFP.
"Some people will tell you: 'I took it and I am fine'," Dopter said.
"But we can see from these few cases that people who were simply trying to lose weight ended up with seriously impaired health -- or even died," he said.
"It is not the worth the risk."
The safety of products using Garcinia cambogia is currently being assessed by the European Food Safety Agency.
The watchdog is also investigating the risk of hydroxycitric acid, an ingredient extracted from the Garcinia plant's fruit, which is also used in supplements promoting weight loss.
France's ANSES called for the list of plants authorised for use in food supplements to be "harmonised" across the European Union.
C.Meier--BTB